GEN Exclusives

More »

GEN News Highlights

More »
Oct 23, 2006

BrainCells and Organon Collaborate on CNS Drugs

  • BrainCells and Organon will collaborate in the discovery and development of drugs for the treatment of central nervous system disorders.

    BrainCells will use its technology in the area of neurogenesis to identify neuroscience applications for compounds formerly in the Organon clinical-stage pipeline. When BrainCells determines the therapeutic utility for a drug candidate, the companies will work together to develop and reposition the drug for its new use.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »